Joseph Pantginis
Stock Analyst at HC Wainwright & Co.
(3.08)
# 1,057
Out of 5,182 analysts
896
Total ratings
40.66%
Success rate
1.28%
Average return
Main Sectors:
Stocks Rated by Joseph Pantginis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Maintains: Buy | $239 → $243 | $223.94 | +8.51% | 24 | Apr 14, 2026 | |
| TVTX Travere Therapeutics | Reiterates: Buy | $47 | $41.44 | +13.42% | 7 | Apr 14, 2026 | |
| CVKD Cadrenal Therapeutics | Maintains: Buy | $32 → $13 | $4.80 | +170.83% | 7 | Apr 7, 2026 | |
| APRE Aprea Therapeutics | Maintains: Buy | $4 → $1.2 | $0.88 | +36.58% | 17 | Mar 31, 2026 | |
| PHAR Pharming Group | Reiterates: Buy | $37 | $17.56 | +110.71% | 18 | Mar 24, 2026 | |
| LCTX Lineage Cell Therapeutics | Reiterates: Buy | $9 | $1.65 | +447.11% | 14 | Mar 24, 2026 | |
| LXRX Lexicon Pharmaceuticals | Reiterates: Buy | $6 | $1.82 | +230.58% | 25 | Mar 23, 2026 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $102 | $35.20 | +189.77% | 36 | Mar 23, 2026 | |
| XOMA XOMA Royalty | Reiterates: Buy | $97 | $39.52 | +145.45% | 26 | Mar 20, 2026 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $60 | $34.94 | +71.72% | 29 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.92 | - | 19 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $5.78 | +124.91% | 1 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $2.40 | +608.33% | 5 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $15 | $12.79 | +17.28% | 16 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $16 | $13.35 | +19.85% | 5 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.63 | - | 13 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $11 | $2.12 | +418.87% | 20 | Jan 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.98 | +345.43% | 29 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 → $310 | $267.37 | +15.94% | 35 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $120 → $136 | $65.09 | +108.94% | 51 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.99 | +504.53% | 1 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $3 | $0.75 | +298.62% | 20 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $7 | $4.65 | +50.54% | 3 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.51 | +1,463.72% | 3 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $6 | $7.09 | -15.37% | 19 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $15 | $1.28 | +1,071.88% | 33 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $9 | $3.66 | +145.90% | 30 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $52 | $33.77 | +53.98% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $57 | $31.74 | +79.58% | 27 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $1.19 | +2,000.66% | 17 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $2.07 | +672.95% | 30 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.84 | - | 26 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.25 | +253.36% | 17 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $42 | $33.76 | +24.41% | 36 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $30 | $26.50 | +13.21% | 1 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $10 | $8.64 | +15.74% | 10 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.61 | - | 23 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $32.87 | +27.78% | 1 | Jun 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $1.27 | +1,002.36% | 2 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.16 | +244.83% | 31 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $2.41 | +4,049.38% | 2 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $2.53 | +137.15% | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $26 | $2.39 | +990.15% | 14 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $280 | $2.49 | +11,144.98% | 3 | Jun 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.67 | +2,424.69% | 1 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $18 | $1.93 | +835.06% | 30 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $5.61 | +328.19% | 18 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.25 | - | 9 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $6.34 | +388.96% | 31 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.60 | +1,893.36% | 1 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.46 | +656.01% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $21.35 | -67.21% | 29 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.70 | +3,497.12% | 4 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.76 | +13,040.60% | 7 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.73 | - | 6 | Dec 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.15 | - | 2 | Jan 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $18 → $33 | $34.31 | -3.82% | 2 | Nov 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 → $78 | $6.28 | +1,143.03% | 1 | Mar 24, 2017 |
Ligand Pharmaceuticals
Apr 14, 2026
Maintains: Buy
Price Target: $239 → $243
Current: $223.94
Upside: +8.51%
Travere Therapeutics
Apr 14, 2026
Reiterates: Buy
Price Target: $47
Current: $41.44
Upside: +13.42%
Cadrenal Therapeutics
Apr 7, 2026
Maintains: Buy
Price Target: $32 → $13
Current: $4.80
Upside: +170.83%
Aprea Therapeutics
Mar 31, 2026
Maintains: Buy
Price Target: $4 → $1.2
Current: $0.88
Upside: +36.58%
Pharming Group
Mar 24, 2026
Reiterates: Buy
Price Target: $37
Current: $17.56
Upside: +110.71%
Lineage Cell Therapeutics
Mar 24, 2026
Reiterates: Buy
Price Target: $9
Current: $1.65
Upside: +447.11%
Lexicon Pharmaceuticals
Mar 23, 2026
Reiterates: Buy
Price Target: $6
Current: $1.82
Upside: +230.58%
Viking Therapeutics
Mar 23, 2026
Reiterates: Buy
Price Target: $102
Current: $35.20
Upside: +189.77%
XOMA Royalty
Mar 20, 2026
Reiterates: Buy
Price Target: $97
Current: $39.52
Upside: +145.45%
Capricor Therapeutics
Mar 13, 2026
Reiterates: Buy
Price Target: $60
Current: $34.94
Upside: +71.72%
Mar 9, 2026
Downgrades: Neutral
Price Target: n/a
Current: $1.92
Upside: -
Feb 25, 2026
Initiates: Buy
Price Target: $13
Current: $5.78
Upside: +124.91%
Feb 23, 2026
Reiterates: Buy
Price Target: $17
Current: $2.40
Upside: +608.33%
Feb 23, 2026
Maintains: Buy
Price Target: $9 → $15
Current: $12.79
Upside: +17.28%
Feb 13, 2026
Upgrades: Buy
Price Target: $16
Current: $13.35
Upside: +19.85%
Jan 29, 2026
Downgrades: Neutral
Price Target: n/a
Current: $0.63
Upside: -
Jan 22, 2026
Upgrades: Buy
Price Target: $11
Current: $2.12
Upside: +418.87%
Jan 13, 2026
Reiterates: Buy
Price Target: $40
Current: $8.98
Upside: +345.43%
Jan 9, 2026
Reiterates: Buy
Price Target: $240 → $310
Current: $267.37
Upside: +15.94%
Dec 22, 2025
Maintains: Buy
Price Target: $120 → $136
Current: $65.09
Upside: +108.94%
Dec 16, 2025
Initiates: Buy
Price Target: $12
Current: $1.99
Upside: +504.53%
Dec 12, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.75
Upside: +298.62%
Dec 5, 2025
Maintains: Buy
Price Target: $21 → $7
Current: $4.65
Upside: +50.54%
Dec 2, 2025
Reiterates: Buy
Price Target: $8
Current: $0.51
Upside: +1,463.72%
Dec 1, 2025
Upgrades: Buy
Price Target: $6
Current: $7.09
Upside: -15.37%
Nov 13, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $1.28
Upside: +1,071.88%
Oct 29, 2025
Maintains: Buy
Price Target: $20 → $9
Current: $3.66
Upside: +145.90%
Oct 20, 2025
Assumes: Buy
Price Target: $52
Current: $33.77
Upside: +53.98%
Oct 8, 2025
Reiterates: Buy
Price Target: $57
Current: $31.74
Upside: +79.58%
Sep 22, 2025
Reiterates: Buy
Price Target: $25
Current: $1.19
Upside: +2,000.66%
Sep 19, 2025
Reiterates: Buy
Price Target: $16
Current: $2.07
Upside: +672.95%
Sep 15, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.84
Upside: -
Aug 21, 2025
Reiterates: Buy
Price Target: $15
Current: $4.25
Upside: +253.36%
Aug 20, 2025
Maintains: Buy
Price Target: $50 → $42
Current: $33.76
Upside: +24.41%
Aug 5, 2025
Maintains: Buy
Price Target: $5 → $30
Current: $26.50
Upside: +13.21%
Aug 4, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $8.64
Upside: +15.74%
Jul 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.61
Upside: -
Jun 30, 2025
Initiates: Buy
Price Target: $42
Current: $32.87
Upside: +27.78%
Jun 25, 2025
Reiterates: Buy
Price Target: $14
Current: $1.27
Upside: +1,002.36%
Jun 24, 2025
Reiterates: Buy
Price Target: $4
Current: $1.16
Upside: +244.83%
Jun 18, 2025
Reiterates: Buy
Price Target: $100
Current: $2.41
Upside: +4,049.38%
Jun 17, 2025
Assumes: Buy
Price Target: $6
Current: $2.53
Upside: +137.15%
Jun 17, 2025
Reiterates: Buy
Price Target: $26
Current: $2.39
Upside: +990.15%
Jun 11, 2025
Reiterates: Buy
Price Target: $280
Current: $2.49
Upside: +11,144.98%
May 19, 2025
Assumes: Buy
Price Target: $17
Current: $0.67
Upside: +2,424.69%
May 6, 2025
Maintains: Buy
Price Target: $40 → $18
Current: $1.93
Upside: +835.06%
Apr 21, 2025
Reiterates: Buy
Price Target: $24
Current: $5.61
Upside: +328.19%
Apr 9, 2025
Reiterates: Neutral
Price Target: n/a
Current: $3.25
Upside: -
Apr 8, 2025
Reiterates: Buy
Price Target: $31
Current: $6.34
Upside: +388.96%
Apr 3, 2025
Initiates: Buy
Price Target: $12
Current: $0.60
Upside: +1,893.36%
Mar 19, 2025
Reiterates: Buy
Price Target: $11
Current: $1.46
Upside: +656.01%
Feb 13, 2025
Maintains: Buy
Price Target: $17 → $7
Current: $21.35
Upside: -67.21%
Oct 2, 2024
Reiterates: Buy
Price Target: $25
Current: $0.70
Upside: +3,497.12%
May 16, 2024
Reiterates: Buy
Price Target: $100
Current: $0.76
Upside: +13,040.60%
Dec 1, 2021
Downgrades: Neutral
Price Target: n/a
Current: $1.73
Upside: -
Jan 31, 2018
Downgrades: Neutral
Price Target: n/a
Current: $1.15
Upside: -
Nov 14, 2017
Assumes: Buy
Price Target: $18 → $33
Current: $34.31
Upside: -3.82%
Mar 24, 2017
Reiterates: Buy
Price Target: $60 → $78
Current: $6.28
Upside: +1,143.03%